micafungin and Empyema--Pleural

micafungin has been researched along with Empyema--Pleural* in 1 studies

Other Studies

1 other study(ies) available for micafungin and Empyema--Pleural

ArticleYear
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    A 62-year-old man with empyema caused by Aspergillus fumigatus was successfully treated with a combination of voriconazole (VRCZ) and micafungin (MCFG). Data regarding the penetration of antifungal agents into pleural fluid are limited. Thus, we measured the concentration of VRCZ and MCFG in his plasma and pleural fluid. Penetration of VRCZ and MCFG into the pleural fluid was excellent. Therefore, the combination therapy using VRCZ and MCFG may contribute to successful management of Aspergillus empyema.

    Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010